13-14 MBB306 Lecture 5 The Herpesviruses - RJ
13-14 MBB306 Lecture 5 The Herpesviruses - RJ
13-14 MBB306 Lecture 5 The Herpesviruses - RJ
BETAHERPESVIRUSES:-- Slow growing viruses with a narrow host range; grow in T-lymphocytes and/or leukocytes. Human cytomegalovirus (HCMV) Human herpesvirus 6 Human herpesvirus 7 HHV-5 HHV-6 HHV-7
HHV-4 HHV-8
[Herpesviruses infecting very many vertebrate animals, including other primates, frogs 2 and elephants have been identified].
HHV-3
HHV-4
Glandular fever/Infectious mononucleosis; Burkitts lymphoma Cytomegalic inclusion disease (CID) in utero, in newborns and in the immunocompromised.
HHV-5
4 12
The linear 152kbp genome contains 3 origins of DNA replication and about 80 ORFs.
HSV DNA replication is by a rolling circle mechanism which takes place in discreet HSV replication compartments.
Replication generates long progeny HSV DNA concatamers which are cleaved and packaged into progeny viral particles.
ICP-27: - regulator of gene expression ICP-0: - promiscuous transactivator; degrades cellular repressors of HSV DNA transcription
ICP-22/ - deregulate the infected cell Us1.5: cycle ICP-47: - primarily a pathogenic protein
All the IE proteins are also defined by possessing VP16-response (TAATGARAT) elements within their promoters. 6 (ICP = Infectious cell polypeptide: Us = Unique short)
HSV Glycoproteins
gD Fusion Trigger
gD Receptors
Host Cell
a). ICP0 an E3 ubiquitin ligase destabilising specific cellular proteins that would otherwise inhibit the HSV life cycle. Creates a cellular environment favourable for HSV DNA transcription
b). ICP 27 - inhibits the host cell splicing of pre-mRNA
All the IE proteins contribute to a redirection of cell metabolism from synthesis of host proteins to synthesis of viral proteins, and develop an active and robust 8 environment.
THE NUCLEOSOME
The chromatin modifications involving HCF are acetylation and methylation of the nucleosome histone core.
HCF/HAT activity opens the nucleosomes in the control regions of the promoters close to the enhancers, by relaxing the connections between the histones and associated DNA. High levels of acetylation make the chromatin more active, allowing transcription. With low or absent HCF, transcription is reduced as the promoters and enhancers cannot be accessed by transactivating factors. 12
Early () - genes
Late (-1 and -2) genes
-- Transcription and expression of the genes is not stimulated by viral DNA replication.
-- -1 genes are transcribed and expressed (at low levels) even in the absence of viral DNA replication, but are greatly stimulated when viral DNA is replicating. -- -2 genes are not transcribed or expressed in the absence of viral DNA replication.
13
HATs
Oct-1
HCF VP16
EXTERIOR ENVIRONMENT
Cell membrane
Cytoplasmic vesicle
Endoplasmic reticulum
CYTOPLASM
Precursor viral glycoproteins
Nucleocapsid + tegument
Nuclear membrane
NUCLEUS
Viral nucleocapsid
+
Empty viral capsid
16
17
Essential in vitro
ICP4
ICP27
ICP0
ICP22/Us1.5
ICP47 Non-essential
in vitro
X
Early gene expression Both ICP4 and ICP27 must be expressed for the lytic cycle to proceed
Viral DNA replication
Immune evasion
X
Late gene expression
Viral structural proteins
Primary and recurrent genital herpes (mainly HSV-2) Generalised and encephalitic neonatal herpes infection (mainly HSV-2) Herpetic keratoconjunctivitis and herpetic encephalitis (mainly HSV-1) Skin infections e.g. herpetic whitlow (mainly HSV-1)
Immunocompromised individuals are at increased risk of HSV infections, in terms of both frequency of infection and greater severity of illness.
19
HERPETIC WHITLOW
6
20
PRIMARY INFECTION
(90%-99%)
(1%-10%)
11
21
EPIDEMIOLOGY
Highly infectious disease usually occurring in children. Virus spread from the upper respiratory tract prior to appearance of rash.
Virus present in skin lesions (as much as 1010 1011virions/ml). VZV causes severe infections in the immunocompromised.
23
Often asymptomatic, but symptoms can include sore throat, swollen cervical lymph nodes and mild fever. May run a prolonged, episodic, course over 12 years. Associated with the cancer, Burkitts Lymphoma in some parts of the world.
24
EM of the EPSTEINBARR VIRUS (EBV) PATIENT with INFECTIOUS MONONUCLEOSIS (GLANDULAR FEVER)
END of LECTURE
26
HATs
SETs
VP16
Oct-1 Oct-1
HSV DNA
Transcription of HSV DNA involving host cell RNA polymerase II
VP16
CYTOPLASM
SETs
HCF
VP16
Oct-1
VP16 HCF